Satralizumab in Aneurysmal Subarachnoid Hemorrhage

NCT05727657 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lost support from the drug manufacturer

Conditions

Aneurysmal Subarachnoid Hemorrhage
Delayed Cerebral Ischemia

Interventions

DRUG: Satralizumab

Sponsor

University of Florida

Collaborators

[object Object]